| Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer B Tran, S Kopetz, J Tie, P Gibbs, ZQ Jiang, CH Lieu, A Agarwal, DM Maru, ... Cancer 117 (20), 4623-4632, 2011 | 825 | 2011 |
| Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents M Mao, F Tian, JM Mariadason, CC Tsao, R Lemos Jr, F Dayyani, ... Clinical cancer research 19 (3), 657-667, 2013 | 332 | 2013 |
| Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience ZQ Jiang, K Yang, R Komaki, X Wei, SL Tucker, Y Zhuang, MK Martel, ... International Journal of Radiation Oncology* Biology* Physics 83 (1), 332-339, 2012 | 188 | 2012 |
| Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer ZY Chen, K Raghav, CH Lieu, ZQ Jiang, C Eng, JN Vauthey, GJ Chang, ... British journal of cancer 112 (6), 1088-1097, 2015 | 175 | 2015 |
| Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors S Kopetz, J Tabernero, R Rosenberg, ZQ Jiang, V Moreno, ... The oncologist 20 (2), 127-133, 2015 | 146 | 2015 |
| Progression-free survival remains poor over sequential lines of systemic therapy in patients with BRAF-mutated colorectal cancer V Morris, MJ Overman, ZQ Jiang, C Garrett, S Agarwal, C Eng, B Kee, ... Clinical colorectal cancer 13 (3), 164-171, 2014 | 142 | 2014 |
| The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer CH Lieu, H Tran, ZQ Jiang, M Mao, MJ Overman, E Lin, C Eng, J Morris, ... PloS one 8 (10), e77117, 2013 | 135 | 2013 |
| N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration I Rigoutsos, SK Lee, SY Nam, S Anfossi, B Pasculli, M Pichler, Y Jing, ... Genome biology 18, 1-21, 2017 | 103 | 2017 |
| Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer MS Lee, EJ McGuffey, JS Morris, G Manyam, V Baladandayuthapani, ... British journal of cancer 114 (12), 1352-1361, 2016 | 97 | 2016 |
| Association between KRAS mutation and lung metastasis in advanced colorectal cancer AAL Pereira, JFM Rego, V Morris, MJ Overman, C Eng, CR Garrett, ... British journal of cancer 112 (3), 424-428, 2015 | 95 | 2015 |
| Circulating DNA demonstrates convergent evolution and common resistance mechanisms during treatment of colorectal cancer AR Thierry, B Pastor, ZQ Jiang, AD Katsiampoura, C Parseghian, ... Clinical Cancer Research 23 (16), 4578-4591, 2017 | 89 | 2017 |
| High-grade neuroendocrine colorectal carcinomas: a retrospective study of 100 patients B Conte, B George, M Overman, J Estrella, ZQ Jiang, AM Sarshekeh, ... Clinical colorectal cancer 15 (2), e1-e7, 2016 | 62 | 2016 |
| Gene Expression Profiling of Ampullary Carcinomas Classifies Ampullary Carcinomas into Biliary-Like and Intestinal-Like Subtypes That Are Prognostic of Outcome MJ Overman, J Zhang, S Kopetz, M Davies, ZQ Jiang, K Stemke-Hale, ... PLoS One 8 (6), e65144, 2013 | 60 | 2013 |
| Clinicopathologic characteristics and gene expression analyses of non-KRAS 12/13, RAS-mutated metastatic colorectal cancer VK Morris, FA San Lucas, MJ Overman, C Eng, MP Morelli, ZQ Jiang, ... Annals of Oncology 25 (10), 2008-2014, 2014 | 58 | 2014 |
| Dual inhibition of EGFR and c-Src by cetuximab and dasatinib combined with FOLFOX chemotherapy in patients with metastatic colorectal cancer CM Parseghian, NU Parikh, JY Wu, ZQ Jiang, L Henderson, F Tian, ... Clinical cancer research 23 (15), 4146-4154, 2017 | 53 | 2017 |
| Association of primary (1°) site and molecular features with progression-free survival (PFS) and overall survival (OS) of metastatic colorectal cancer (mCRC) after anti … MS Lee, SM Advani, J Morris, ZQ Jiang, GC Manyam, D Menter, ... Journal of Clinical Oncology 34 (15_suppl), 3506-3506, 2016 | 49 | 2016 |
| Modeling of patient-derived xenografts in colorectal cancer A Katsiampoura, K Raghav, ZQ Jiang, DG Menter, A Varkaris, MP Morelli, ... Molecular cancer therapeutics 16 (7), 1435-1442, 2017 | 45 | 2017 |
| A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer JJ Arcaroli, WM Tai, R McWilliams, S Bagby, PJ Blatchford, ... International journal of cancer 138 (1), 195-205, 2016 | 45 | 2016 |
| Circulating tumor DNA (ctDNA) utilizing a high-sensitivity panel to detect minimal residual disease post liver hepatectomy and predict disease recurrence. MJ Overman, JN Vauthey, TA Aloia, C Conrad, YS Chun, AAL Pereira, ... Journal of Clinical Oncology 35 (15_suppl), 3522-3522, 2017 | 41 | 2017 |
| A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy ZQ Jiang, G Varadhachary, X Wang, S Kopetz, JE Lee, H Wang, R Shroff, ... Annals of oncology 24 (9), 2349-2353, 2013 | 35 | 2013 |
